Edge Wealth Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Edge Wealth Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,000	Closed	-$27K	–	548
2016 Q3	$27K	Sell	2,000 -1,000	-33%	-$10K	0.01%	243
2016 Q2	$22K	Hold	3,000	–	–	0.01%	248
2016 Q1	$19K	Hold	3,000	–	–	0.01%	237
2015 Q4	$19K	Hold	3,000	–	–	0.01%	246
2015 Q3	$17K	Hold	3,000	–	–	0.01%	247
2015 Q2	$25K	Hold	3,000	–	–	0.01%	239
2015 Q1	$25K	Sell	3,000 -500	-14%	-$3.7K	0.01%	239
2014 Q4	$24K	Sell	3,500 -2,000	-36%	-$12.5K	0.01%	243
2014 Q3	$30K	Buy	5,500 +2,500	+83%	+$14.6K	0.01%	231
2014 Q2	$19K	Hold	3,000	–	–	0.01%	255
2014 Q1	$24K	Hold	3,000	–	–	0.01%	227
2013 Q4	$20K	Hold	3,000	–	–	0.01%	227
2013 Q3	$55K	Hold	3,000	–	–	0.03%	140
2013 Q2	$53K	Buy	+3,000	New	+$53.2K	0.04%	127

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Edge Wealth Management's ARIA Position: Q4 2016 in Review

Edge Wealth Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2016, closing a stake of 2,000 shares — an estimated $27K sold.

Edge Wealth Management first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $55K in Q3 2013. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

Edge Wealth Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Edge Wealth Management sold 2,000 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $27K.
Edge Wealth Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
Edge Wealth Management's Ariad Pharmaceuticals Inc position peaked at $55K in Q3 2013.
200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on Edge Wealth Management's 13F filing for Q4 2016, filed 24 Jan 2017.